Stock listing
Exicure, Inc.
Selected listing: A40L5C · LS · EUR · DE
Exicure, Inc. (Lang & Schwarz: A40L5C), Health Technology. Latest release Sep 16, 2026: Exicure Receives Nasdaq Extension to Regain Compliance…
- Ticker
- Lang & Schwarz: A40L5C
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- Lang & Schwarz
- Currency
- EUR
Latest news from Exicure, Inc.
Exicure Receives Nasdaq Extension to Regain Compliance with Stockholders’ Equity Requirement
September 16, 2026
Exicure to Settle GPCR Therapeutics Clinical Milestone Payment Through Equity Issuance
August 3, 2026
Exicure Announces Board and Committee Changes
June 30, 2026
Exicure Announces Receipt of Nasdaq Notice Regarding Minimum Stockholders’ Equity Requirement
June 10, 2026
Exicure Announces Receipt of Nasdaq Delinquency Notice and Filing of Form 10-Q
June 1, 2026
Research Exicure, Inc.
Alternate listings
XCUR:NASDAQ
US · USD
Alternate listing for Exicure, Inc.; the primary context on this page is A40L5C:LS.
2H0:MUN
DE · EUR
Alternate listing for Exicure, Inc.; the primary context on this page is A40L5C:LS.
A40L5C:LSX
DE · EUR
Alternate listing for Exicure, Inc.; the primary context on this page is A40L5C:LS.
XCUR:BOATS
US · USD
Alternate listing for Exicure, Inc.; the primary context on this page is A40L5C:LS.
2H0:GETTEX
DE · EUR
Alternate listing for Exicure, Inc.; the primary context on this page is A40L5C:LS.
2H0:FWB
DE · EUR
Alternate listing for Exicure, Inc.; the primary context on this page is A40L5C:LS.
2H0:SWB
DE · EUR
Alternate listing for Exicure, Inc.; the primary context on this page is A40L5C:LS.
2H0:TRADEGATE
DE · EUR
Alternate listing for Exicure, Inc.; the primary context on this page is A40L5C:LS.